Vectura [1] is touting an announcement from Novartis that it will begin a late-stage trial of a new COPD therapy in 2007 that incorporates a drug Vectura developed. Novartis expects to ask for marketing approval of QVA149--a combinatorial therapy--in 2010. Report [2]
Links:
[1] http://www.fiercebiotech.com/story/vectura-to-acquire-innovata-in-243m-deal/2006-11-17
[2] http://www.forbes.com/business/feeds/afx/2006/11/29/afx3211674.html